STK35 and familial dilated cardiomyopathy: In the present study, we used rAAV9-STK35 and found increased expression of STK35 in the heart, which increased microvascular density, suppressed fibrosis, and ameliorated heart functions in diabetic mice, suggesting that STK35 is a novel gene target for preventing and treating DCM.